CGM Innovations to Improve Diabetes Management: The Payer Value Proposition of a Next-Generation rtCGM System

This event is not certified for continuing education credit.

This non-promotional, sponsored webinar is designed to educate managed care professionals around the latest CGM innovations and overall outcomes relevant to care quality and clinically appropriate diabetes management. The live, non-CE webinar is intended to improve managed care professionals’ knowledge and competence with a timely update on the benefits of a recently approved rtCGM system and its potential impact on diabetes management policies and outcomes. The 45-minute presentation and panel discussion will include an in-depth review of the value proposition of the new system from a diabetes specialist and a health plan medical director.

Webcast Topics

• Review clinical trials supporting the adult and pediatric/adolescent approval of the Dexcom G7 rtCGM system
• Outline unique features of the G7, including sensor size and insertion sites and system warm-up/integration
• Assess the value proposition of the G7 rtCGM system from the patient/clinician and payer perspectives

Expert Faculty Presenters:

Jeffrey Dunn, PharmD, MBA Chief Clinical Officer Cooperative Benefits Group (CBG) < Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP Endocrine Clinical Pharmacy Specialist Co-Director, Endocrine Disorders in Pregnancy Cleveland Clinic Endocrinology & Metabolism Institute Roy Gandolfi, MD Medical Director SelectHealth